HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome. [electronic resource]
Producer: 20140620Description: e47-8 p. digitalISSN:- 1534-6080
- Adult
- Antiviral Agents -- administration & dosage
- Carbamates
- Drug Therapy, Combination
- Hepatitis C, Chronic -- complications
- Humans
- Hyper-IgM Immunodeficiency Syndrome -- complications
- Imidazoles -- administration & dosage
- Immunoglobulin M -- immunology
- Interferon-alpha -- administration & dosage
- Liver Transplantation
- Male
- Polyethylene Glycols -- administration & dosage
- Proline -- administration & dosage
- Pyrrolidines
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.